NewsIn memory
Duke Ellington: Understanding Lung Cancer
Duke Ellington died of lung cancer in New York in May 1974. No stage or treatment was ever made public. What lung cancer is, and how it is treated today.
Original commentary from the Cancer Explained editorial team.
Historical context: this page explains an event dated 1974. It was published as an explainer on July 12, 2026 and is not breaking news.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
What the record says
Duke Ellington was a composer, pianist, and bandleader. PBS American Masters gives his dates as 29 April 1899 to 24 May 1974, and states that he died of lung cancer in New York City in May 1974.
That is the whole of the medical record available here. No stage, no treatment, no timeline was made public in the sources checked, and this page does not fill those gaps.
What his date of death does offer is a useful vantage point. Lung cancer in 1974 and lung cancer now are recognizably the same disease treated in a different world.
Two diseases under one name
NCI divides lung cancer into two main groups, and the split drives almost everything else.
Non-small cell lung cancer is the more common. It has several types, named for what the cells look like under a microscope. Squamous cell carcinoma forms in the thin, flat cells lining the inside of the lungs. Adenocarcinoma begins in the cells that line the alveoli, the tiny air sacs, and make substances such as mucus. Large cell carcinoma starts in several kinds of large cell. Less common types include adenosquamous carcinoma, sarcomatoid carcinoma, salivary gland carcinoma, carcinoid tumor, and unclassified carcinoma.
Small cell lung cancer is the other group. It grows and spreads faster and is staged differently.
In 1974, that distinction was known. Almost nothing beyond it was. A tumor was a tumor of a certain size in a certain place. Our page on lung cancer covers how the types differ now.
What surgery looks like
NCI describes four operations for lung cancer, and they scale with how much has to go.
A wedge resection removes the tumor and some normal tissue around it. Take a slightly larger piece and it becomes a segmental resection.
A lobectomy removes a whole lobe. The left lung has two lobes, the right has three.
A pneumonectomy removes an entire lung.
A sleeve resection removes part of a bronchus, one of the two tubes leading from the windpipe into the lungs.
After surgery, some people receive chemotherapy or radiation to kill cells that were left behind. NCI calls that adjuvant therapy.
What changed after 1974
The list of treatments NCI now records for non-small cell lung cancer runs well past surgery, radiation, and chemotherapy. It includes targeted therapy, immunotherapy, laser therapy, photodynamic therapy, cryosurgery, and electrocautery.
Targeted therapy depends on knowing what genetic change is driving a particular tumor, which requires testing the tissue rather than just looking at it. Immunotherapy depends on understanding how tumors switch off immune cells. Neither concept existed in usable form in 1974.
Low-dose CT screening did not exist either. Neither did the trials that established who benefits from it.
The numbers moved with the science, and the movement is real but modest. SEER's series shows five-year relative survival for lung and bronchus cancer at 11.74 percent for 1975. The current figure, for cases from 2016 to 2022, is 29.5 percent.
When to get checked
NCI lists these for non-small cell lung cancer. Check with a doctor about:
- Chest discomfort or pain
- A cough that does not go away or gets worse over time
- Trouble breathing, or wheezing
- Blood in sputum, the mucus coughed up from the lungs
- Hoarseness
- Trouble swallowing
- Loss of appetite, or weight loss for no known reason
- Fatigue
- Swelling in the face, or in the veins of the neck
That last sign is worth acting on quickly. It can mean a tumor is pressing on the large vein returning blood to the heart.
Sometimes there are no symptoms at all, and the cancer turns up on a chest x-ray done for something else. Our page on cancer symptoms covers what makes a symptom worth investigating.
The screening rule, and who it covers
The US Preventive Services Task Force recommends yearly low-dose CT for adults aged 50 to 80 who have a 20 pack-year smoking history and either smoke now or quit within the past 15 years.
Screening stops once someone has not smoked for 15 years, or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.
That is a narrow gate, and it is narrow on purpose. Low-dose CT finds a lot of small nodules, most of them harmless, and each one leads to more scans or a biopsy. The benefit outweighs that only in people whose risk is high enough.
Where the disease sits today
An American Cancer Society projection published by SEER puts 2026 at 229,410 new lung and bronchus cancers in the United States and 124,990 deaths. That is 20.0 percent of all cancer deaths, more than any other cancer type.
By stage, five-year relative survival is 65.5 percent while the cancer is confined to the lung, 38.2 percent once it reaches nearby lymph nodes, and 10.5 percent once distant. About 24 percent are found at that first stage, and 51 percent are already distant.
About 5.2 percent of people will be diagnosed with lung or bronchus cancer at some point in life.
These are group figures spanning both major types, all ages, and years of shifting treatment. They cannot describe one person.
What this story cannot tell you
A cause of death recorded in 1974 tells us nothing about what type of lung cancer Ellington had, what stage it was, or what treatment he received. None of that was published.
It also tells us nothing about anyone else. Two people with the same named diagnosis in the same year can have entirely different diseases once the cell type and genetics are known, and in 1974 nobody could look.
The honest use of a death like this is as a marker of distance traveled. Survival has more than doubled since then, which is real progress and still leaves lung cancer as the leading cause of cancer death in the United States.
Sources
- PBS American Masters, Duke Ellington — https://www.pbs.org/wnet/americanmasters/duke-ellington-about-duke-ellington/586/
- NCI PDQ, Non-Small Cell Lung Cancer Treatment (Patient Version) — https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq
- SEER Cancer Stat Facts, Lung and Bronchus Cancer — https://seer.cancer.gov/statfacts/html/lungb.html
- USPSTF, Lung Cancer: Screening — https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening
How this article was prepared
An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.
The National Cancer Information Foundation publishes Cancer Explained. This page is for learning. It is not medical advice and does not suggest a test or treatment.
See an error, old source, or unclear wording? Tell us.
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Put the story in context
Prevention, possible warning signs, screening, and diagnosis
This story relates to Lung cancer. The information below is general: it does not reveal anything else about a public person’s health, and not every point applies to every cancer. Personal advice depends on age, symptoms, family history, exposures, and medical history.
Prevention and risk reduction
Not every cancer can be prevented. Avoiding tobacco, protecting skin from ultraviolet radiation, limiting alcohol, staying active, and receiving recommended HPV or hepatitis B vaccination can lower the risk of certain cancers. A risk factor is not a prediction or a cause in one individual.
Symptoms and possible early signs
Possible signs vary and are often caused by conditions other than cancer. Changes worth discussing include a new lump, unexplained bleeding or weight loss, a persistent cough, lasting bowel or bladder changes, a changing skin spot, or symptoms that persist or worsen. Some early cancers cause no symptoms.
Screening and early detection
Screening looks for certain cancers before symptoms begin. Recommended tests exist only for some cancers and depend on age and risk. Screening can have benefits and harms; it is not the same as evaluating a new symptom, and there is no single routine scan or blood test that reliably screens for every cancer.
How cancer is diagnosed
Diagnosis may involve a history and exam, imaging, laboratory tests, and often a biopsy. Pathology can identify the cancer type and may test biomarkers that guide treatment. Symptoms, screening results, tumor markers, or online stories alone cannot confirm cancer.
Learn about this story’s cancer topic
A public story may encourage questions, but it should not be used to estimate your risk or choose testing. Contact a healthcare professional about a persistent or concerning change. Seek urgent care for severe or rapidly worsening symptoms.